Frontlight ResearchEarly access
Trial site
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Rendelointézet
- 3running trials
- 14closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Bladder cancer2 trials
- Head and neck cancer2 trials
- Kidney cancer2 trials
- Metastatic breast cancer2 trials
- Colorectal cancer1 trial
- COPD1 trial
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Melanoma1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 313 trials
- Phase 23 trials
- Phase 2/31 trial
- Status
- Completed14 trials
- Active, not recruiting3 trials
- Lead sponsor
- Merck Sharp & Dohme LLC8 trials
- Daiichi Sankyo2 trials
- Incyte Corporation2 trials
- AstraZeneca1 trial
- Hoffmann-La Roche1 trial
- and 3 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
A study of MK7684A versus Pembrolizumab in PD-L1 Positive Metastatic NSCLC (KEYVIBE-003)
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026